Paper Details

  1. Home
  2. Paper Details

Inhaled iloprost for the control of pulmonary hypertension.

Author: HammerschmidtStefan, KrugSabine, SablotzkiArmin, SeyfarthHans-Juergen, WirtzHubert

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Iloprost, a stable prostacyclin analogue, is a mainstay in pulmonary arterial hypertension (PAH) therapy. While intravenous administration is associated with severe side effects, inhaled iloprost has proven effective and safe for first-line therapy. Combination therapy with endothelin-receptor antagonists or sildenafil shows encouraging results and warrants further investigation.
Paper Details　
Original Abstract of the Article :
Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by an elevated pulmonary arterial pressure and vascular resistance with a poor prognosis. Various pulmonary and extrapulmonary causes are now recognized to exist separately from the idiopathic form of pulmonary hyperte...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686263/

データ提供：米国国立医学図書館（NLM）

Inhaled Iloprost for Pulmonary Hypertension

This study examines the use of inhaled iloprost, a medication that mimics the effects of prostacyclin, to treat pulmonary arterial hypertension (PAH). Think of it as discovering a new desert plant that can soothe and heal a traveler's lungs. PAH is a serious condition that affects the heart and lungs, making it difficult to breathe. This research investigates the effectiveness of inhaled iloprost as a treatment option for this debilitating disease.

The study highlights the potential of inhaled iloprost for treating PAH. It suggests that this medication can improve symptoms and potentially extend life expectancy for PAH patients. It's like finding a hidden oasis in the desert, providing a much-needed respite from the harsh conditions and offering a chance for survival.

The Promise of New Treatments

This study offers hope for PAH patients, suggesting that new treatments are being developed to improve their quality of life and potentially cure this debilitating disease. It's a reminder that the desert of medical research is full of hidden oases of hope, and we need to keep searching for new solutions to conquer challenging health problems.

The Importance of Continuous Research

This study underscores the importance of continuous research in the field of pulmonary hypertension. Just as a traveler needs to keep exploring new paths in the desert, scientists need to keep searching for new and better treatments for PAH. This research provides valuable insights that can guide our efforts towards developing more effective therapies for this challenging disease.

Dr. Camel's Conclusion

This study reminds us that the journey towards conquering pulmonary hypertension continues. Just as a traveler needs to keep seeking water and sustenance in the desert, we need to keep searching for new ways to treat this debilitating disease. This research gives us hope that we are moving closer to finding effective treatments and improving the lives of PAH patients.

Date :
  1. Date Completed 2009-06-19
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19475782

DOI: Digital Object Identifier

PMC2686263

Related Literature

Article Analysis
・Side Effects of iloprost
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.